Development↦Biobanking↦Documentation↦Non-Conformities
What is it? Why is it important?
A non-conformity (NC) is a non-fulfillment of some given requirement that can or might affect the characteristics and/or the quality of Biological Material (BM) and/or the QMS of the biobank (e.g. non-compliance with Quality-Control-Indicators). Once detected, the NC is documented and evaluated regarding further actions.
NCs are a consequence of but not limited to:
- Staff errors (e.g. centrifugation at room temperature instead of required 4°C, data error entries)
- Lack or erroneous staff trainings
- Erroneous biobanking forms lacking relevant processing instructions, and lack of applicable SOPs/WIs
- Equipment failure (e.g. freezer breakdown)
- Misuse of equipment (e.g. use of non-calibrated pipettes)
- Deliberate actions (e.g. destruction of BM, abstain from using proper storage conditions, data hacking)
- Catastrophic events (e.g. fire or flood)
Occurrence of NCs trigger:
- Corrective and preventive actions (CAPAs) with the aim to prevent re-occurrence of NCs (e.g. risk control-measures)
- Documentation of these actions and their associated results (satisfying or not) in a Risk Assessment Form (RAF)
What do I need to do?
Based on defined sample workflow procedures set-up a NC surveillance and reporting system that includes the:
- Identification of NCs. For each workflow activity:
- Provide instructions (e.g. SOPs/WIs / Checklists) that must be adhered to (e.g. train staff)
- Perform a risk assessment and define NC risks. Train staff on risk identification
- Plan intermittent quality compliance checks
- Reporting of NCs: Through quality checks and/or spontaneous staff reporting. Provide a reporting form for the description of NCs (e.g. date of event, affected activities, responsible person(s), if applicable risk control-measures)
- Management of reported NCs: Make a root cause analysis and decide if immediate or delayed corrective actions are needed. Define corrective and preventive actions (CAPAs) and follow-up procedures. Document its strategy in a RAF
More
Regarding NC management additional questions to address are:
- Who is responsible for NC root-cause analysis?
- Who and how are CAPA actions implemented?
- Who is responsible to evaluate the efficacy of implemented CAPAs (e.g. follow-up procedures)
Where can I get help?
Your local Research Support Centre↧ can assist you with experienced staff regarding this topic
Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch
Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch
Bern, Department of Clinical Research (DCR), dcr.unibe.ch
Geneva, Clinical Research Center (CRC), crc.hug.ch
Lausanne, Clinical Research Center (CRC), chuv.ch
St. Gallen, Clinical Trials Unit (CTU), h-och.ch
Zürich, Clinical Trials Center (CTC), usz.ch
The Swiss Biobanking Platform (SBP) can provide you with support on this topic.
SBP Documents
SOPs, Forms and Templates – see in particular
- Non-conformity management SOP
- Non-conformity Report
- Non-conformity Log
References
ISO 20387:2018 Biotechnology - Biobanking (access liable to cost) - General Requirements for Biobanking – see in particular section
- 8.7 Corrective action for nonconforming output